Cancer

News

Lilly's CEO looks to M&A, but not for CAR-T or gene therapie...

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others

News

Liquid biopsy-based system could prevent cancer from spreadi...

Angle’s liquid biopsy system has been used in new cancer research that could provide a novel way to treat breast cancer and other tumours, by stopping or suppressing their spread from the o

News

UroGen's urothelial cancer drug hits target, could prevent s...

Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead d

News

UroGen appoints former Novartis cancer chief Barrett as CEO

Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring its potential urothelial cancer drug to market.

News

Sanofi gets opt-in rights to two Regeneron cancer drugs

Sanofi and Regeneron have restructured and extended their immune-oncology discovery and development agreement, giving the French drugmaker rights to opt-in to development and marketing of t

News